In this episode we're joined by Dr Stefan Nilsson, founder and CEO of Lipigon Pharmaceuticals, where he discusses the challenges and opportunities in treating metabolic diseases such as dyslipidemia. We also go on to discuss how Lipigon operates as a virtual biotech, allowing it to remain nimble in its efforts to develop novel therapies against a wide range of diseases. Lipigon was founded in 2010 based on over 50 years of research in lipid biology at Umea University in Sweden. Lipigon...
All content for Biotech Frontiers is the property of HitGen and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode we're joined by Dr Stefan Nilsson, founder and CEO of Lipigon Pharmaceuticals, where he discusses the challenges and opportunities in treating metabolic diseases such as dyslipidemia. We also go on to discuss how Lipigon operates as a virtual biotech, allowing it to remain nimble in its efforts to develop novel therapies against a wide range of diseases. Lipigon was founded in 2010 based on over 50 years of research in lipid biology at Umea University in Sweden. Lipigon...
In this episode we're joined by Dr Stefan Nilsson, founder and CEO of Lipigon Pharmaceuticals, where he discusses the challenges and opportunities in treating metabolic diseases such as dyslipidemia. We also go on to discuss how Lipigon operates as a virtual biotech, allowing it to remain nimble in its efforts to develop novel therapies against a wide range of diseases. Lipigon was founded in 2010 based on over 50 years of research in lipid biology at Umea University in Sweden. Lipigon...
Biotech Frontiers
In this episode we're joined by Dr Stefan Nilsson, founder and CEO of Lipigon Pharmaceuticals, where he discusses the challenges and opportunities in treating metabolic diseases such as dyslipidemia. We also go on to discuss how Lipigon operates as a virtual biotech, allowing it to remain nimble in its efforts to develop novel therapies against a wide range of diseases. Lipigon was founded in 2010 based on over 50 years of research in lipid biology at Umea University in Sweden. Lipigon...
